Evidence map›Paper›PMID 35148493›Full record

ArticleAmerican journal of respiratory and critical care medicine2022

Reply to Kalverda

Sreyankar Nandy, Rebecca A Raphaely, Ashok Muniappan, Angela Shih, Benjamin W Roop, Amita Sharma, Colleen M Keyes, Thomas V Colby, Hugh G Auchincloss, Henning A Gaissert and 19 more

Abstract readLetterComment
In one paragraph

Article in American journal of respiratory and critical care medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Microscopic Small Airway Abnormalities Identified in Early Idiopathic Pulmonary FibrosisAmerican journal of respiratory and critical care medicine · 2024
    Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors.

Sreyankar NandyMassachusetts General Hospital Boston, Massachusetts.ORCID 0000-0002-2553-7109
Rebecca A RaphaelyMassachusetts General Hospital Boston, Massachusetts.
Ashok MuniappanMassachusetts General Hospital Boston, Massachusetts.
Angela ShihMassachusetts General Hospital Boston, Massachusetts.
Benjamin W RoopMassachusetts General Hospital Boston, Massachusetts.
Amita SharmaMassachusetts General Hospital Boston, Massachusetts.
Colleen M KeyesMassachusetts General Hospital Boston, Massachusetts.
Thomas V ColbyMayo Clinic Arizona Scottsdale, Arizona.
Hugh G AuchinclossMassachusetts General Hospital Boston, Massachusetts.
Henning A GaissertMassachusetts General Hospital Boston, Massachusetts.
Michael LanutiMassachusetts General Hospital Boston, Massachusetts.
Christopher R MorseMassachusetts General Hospital Boston, Massachusetts.
Harald C OttMassachusetts General Hospital Boston, Massachusetts.
John C WainMassachusetts General Hospital Boston, Massachusetts.
Cameron D WrightMassachusetts General Hospital Boston, Massachusetts.
Maria L Garcia-MolinerRhode Island Hospital and Alpert Medical School Providence, Rhode Island.
Maxwell L SmithMayo Clinic Arizona Scottsdale, Arizona.
Paul A VanderLaanHarvard Medical School Boston, Massachusetts.
Sarita R BerigeiMassachusetts General Hospital Boston, Massachusetts.
Mari Mino-KenudsonMassachusetts General Hospital Boston, Massachusetts.
Nora K HorickMassachusetts General Hospital Boston, Massachusetts.
Lloyd L LiangMassachusetts General Hospital Boston, Massachusetts.
Diane L DaviesMassachusetts General Hospital Boston, Massachusetts.
Margit V SzabariMassachusetts General Hospital Boston, Massachusetts.
Peter CaravanHarvard Medical School Boston, Massachusetts.
Benjamin D MedoffMassachusetts General Hospital Boston, Massachusetts.
Andrew M TagerMassachusetts General Hospital Boston, Massachusetts.
Melissa J SuterMassachusetts General Hospital Boston, Massachusetts.
Lida P HaririMassachusetts General Hospital Boston, Massachusetts.

Funding

In vivo endobronchial OCT for IPF diagnosis and therapy response assessmentR01HL152075 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI HARIRI, LIDA P · 2020 to 2024
$4.0M
Low risk in vivo diagnosis of IPF with optical imagingK23HL132120 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI HARIRI, LIDA P · 2016 to 2020
$896k
Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) P41EB015903NHLBI NIH HHS K23 HL132120NHLBI NIH HHS R01 HL152075NIH HHS K23HL132120NIH HHS R01HL152075
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Idiopathic Pulmonary FibrosisTomography, Optical CoherenceHumansLung

Identifiers

PMID35148493
PMCPMC9838623

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.